Skip to main content
OpenTrials

Clinical trial condition

Extranodal NK/T-cell Lymphoma

Explore clinical trials studying Extranodal NK/T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

11 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Extranodal NK/T-cell Lymphoma trial results

Active, not recruiting

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

NCT04414163

Conditions
Extranodal NK/T-cell Lymphoma, Extranodal NK/T-cell Lymphoma, Nasal Type, Lymphoma, +5 more
Locations
  • Chonnam National University Hwasun Hospital Gwangju, South Korea
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Active, not recruiting

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

NCT04526834

Conditions
Anaplastic Large Cell Lymphoma, Diffuse Large B Cell Lymphoma, Extranodal NK/T-cell Lymphoma, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Baylor College of Medicine Houston, Texas, United States
  • The University of Texas MD Anderson Cancer Centre Houston, Texas, United States
View Trial Details
Completed

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

NCT03493451

Conditions
ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
Locations
  • British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 24 locations
View Trial Details

Related conditions